ArticleJournal for immunotherapy of cancer2025

Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models.

Jian Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.